0 results available. Select is focused ,type to refine list, press Down to open the menu,
Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...
The following section summarizes insights on Novartis AG ADR's Cash Conversion Cycle:
We've identified the following companies as similar to Novartis AG ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Cash Conversion Cycle in the efficiency category include:
A metric that compares the amount of days it takes a company to sell inventory and collect receivables relative to the amount of days afforded to pay ...
Cash Conversion Cycle is defined as:
(+) Days Inventory Outstanding
(+) Days Sales Outstanding
(-) Days Payables Outstanding
(=) Cash Conversion Cycle
Cash Conversion Cycle for Novartis is calculated as follows:
(+) Days Inventory Outstanding [ 166 days ]
(+) Days Sales Outstanding [ 51 days ]
(-) Days Payables Outstanding [ 135 days ]
(=) Cash Conversion Cycle [ 82 days ]
The tables below summarises the trend in Novartis’s inventory turnover over the last five years:
| Fiscal Year | Days Inventory Outstanding | Days Sales Outstanding | Days Payables Outstanding | Cash Conversion Cycle |
|---|---|---|---|---|
| 2020-12-31 | 158 days | 60 days | 131 days | 88 days |
| 2021-12-31 | 221 days | 67 days | 176 days | 113 days |
| 2022-12-31 | 218 days | 67 days | 169 days | 117 days |
| 2023-12-31 | 199 days | 59 days | 153 days | 105 days |
| 2024-12-31 | 166 days | 51 days | 135 days | 82 days |
Cash Conversion Cycle is a metric that compares the amount of days it takes a company to sell inventory and collect receivables relative to the amount of days afforded to pay bills. It attempts to measure the time between the outflow and inflow of cash in the sales cycle.
For example, many companies buy inventory on credit as well as sell products on credit. These actions would increase the company’s Accounts Payable liability and Accounts Receivable asset, respectively. However, cash has not yet been involved in these transactions until the company actually pays its Accounts Payables or collects its Accounts Receivables. The Cash Conversion Cycle attempts to measure the time between these cash outflows and inflows.
A negative figure suggests a company is able to receive payments for product sales before having to pay suppliers. This is good for Net Working Capital and free cash flow.
Read more about days inventory outstanding, days sales outstanding, and days payables outstanding
The chart above depicts the distribution of cash conversion cycle for companies operating in the Healthcare sector in the Developed economic region. Over 1,800 companies were considered in this analysis, and 1,732 had meaningful values. The average cash conversion cycle of companies in the sector is -42 days with a standard deviation of 717 days.
Novartis AG ADR's Cash Conversion Cycle of 82 days ranks in the 55.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,804 |
| Included Constituents | 1,732 |
| Min | -6,889 days |
| Max | 1,085 days |
| Median | 59 days |
| Mean | -42 days |
| Standard Deviation | 717 days |
You can find companies with similar cash conversion cycle using this stock screener.